- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Canadian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
2
1 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
TRUL | CA$9.10 | -43.7% | 20.1% | CA$1.5b | CA$23.51 | PS1.1x | E59.5% | n/a | ||
HLS New | CA$3.46 | 3.9% | -7.2% | CA$116.0m | CA$5.66 | PS1.4x | E71.8% | 0% |
Page 1 of 1